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Dear editor, 
It is well known that huge research networks have been initiated by the EU to establish in 
vitro test systems for toxicity testing (Liebsch et al., 2011; Bolt, 2013; Krug et al., 2013). A 
letter published in the current issue of this journal discussed the impressive progress made in 
this field of research in recent years (Hammad, 2013; Knobeloch et al., 2012; Zellmer et al., 
2010; Godoy et al., 2009, 2010a, b). Indeed, in vitro systems have massively promoted our 
understanding of mechanisms of toxicity (Valente et al., 2012; Kroll et al., 2012; Vávrová et 
al., 2011; Clift et al., 2011; Meyer et al., 2011; Schug et al., 2013; Braeuning et al., 2012; 
Sogorb et al., 2007; Lee at al., 2006). However, critical comments have been published con-
cerning the perspectives for full replacement of animal experiments by in vitro systems (Adler 
et al., 2011). An expert panel confirmed that it may take approximately seven to nine years to 
replace animal experiments for skin sensitization. For toxicokinetics a timeframe of five to 
seven years was suggested (Adler et al., 2011). However, for more complex systemic in vivo 
tests, such as repeated dose toxicity, carcinogenicity and reproductive toxicity a time horizon 
could not yet be given by the expert panel. This opinion confirms a previous analysis of an-
other expert group that came to a similarly pessimistic conclusion (Lilienblum et al., 2008). 
One reason why it is difficult to establish in vivo relevant in vitro systems is that isolated and 
cultivated primary cells usually differ strongly from the corresponding cell type in an organ-
ism. For example, when primary hepatocytes are isolated from their normal microenviron-
ment hundreds of genes are up or down regulated (Zellmer et al., 2010). Although not impos-
sible it is technically challenging to establish culture conditions under which at least some of 
the deregulated genes return to in vivo like levels (Godoy et al., 2009, 2010a, b). 
Other reasons why the replacement of animal experiments is difficult are (1) difficulties to 
include xenobiotic metabolism into in vitro assays, (2) difficulties to capture interactions be-
tween different cell types, (3) problems to extrapolate from in vivo doses to in vitro concentra-
tions, (4) difficulties in simulating the consequences of long term exposures in vitro, (5) diffi-
culties in extrapolating from perturbed pathways or biomarkers in vitro to adverse effects in 
vivo (Tice et al., 2013). 
However, a further critical aspect may have been underestimated in the recent discussion 
about possibilities and limitations of in vitro systems. Due to their complex architecture and 
organization organs have possibilities to compensate stress situations that may be lost in vitro 
(Hoehme et al., 2010). In our ongoing research we observed an intriguing example concerning 
ammonia detoxification (Schliess et al., 2013; Ghallab et al., 2014). In normal liver ammonia 
is detoxified in a periportal compartment of the liver lobule by the urea cycle, while ammonia 
that leaks from the periportal to the pericentral region is further metabolized by glutamine 
synthetase. As long as the interplay between the periportal and pericentral compartments is 
balanced a periportally expressed enzyme, glutamate dehydrogenase fuels ammonia into the 
urea cycle by catalyzing a reaction by which glutamate forms -ketoglutorate and ammonia. 
After intoxication of mice with either CCl4 or paracetamol which destroys the pericentral but 
not the periportal compartment of the liver lobules the capacity of the liver to detoxify ammo-
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nia is compromised. Under these stressed conditions glutamate dehydrogenase begins to cata-
lyze an inverse reaction. Instead of producing ammonia, the latter became consumed by the 
reaction ‘ammonia plus -ketoglutorate forms glutamate’. Although, we intensively study 
hepatocyte in vitro systems we found it extremely difficult to reproduce this switch of gluta-
mate dehydrogenase in vitro. Unfortunately, we are still far from being able to simulate com-
plex situations such as microarchitecture and compartmentation of organs. It may be possible 
to fully replace animal experiments by in vitro systems in future. This will be the case when 
we (i) have understood all relevant mechanisms of toxicity, interactions between cell types 
and organs including their compensatory mechanisms, (ii) have established in vitro systems 
that correctly recapitulate all mechanisms. The time horizon for such ambitious goals will be 
rather centuries than decades. In the meantime we should not neglect in vivo research. We will 
need more knowledge about normally functioning and chemically compromised organs and 
organisms to establish in vitro systems which are more than just in vitro artefacts. 
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